Literature DB >> 20233010

Percentages of CD4+ T regulatory cells and HLA-DR expressing monocytes in severe intra-abdominal infections.

Qiang Fu1, Naiqiang Cui, Wenli Yu, Chao Du.   

Abstract

To study the immune status of patients with severe abdominal infections, we assayed percentages of CD4+ T regulatory cells (CD4+CD25+FOXP3+ Treg) and human leukocyte antigen DR (HLA-DR) expressing CD14+ cells in peripheral blood. A total of 46 subjects with varying acute physiology and chronic health evaluation II (APACHE II) scores were included in the study. There was a significant (p < 0.01) increase in the percentage of CD4+CD25+FOXP3+ Treg and a significant (p < 0.01) decrease in HLA-DR expressing CD14+ cells with increasing APACHE II score. Such modifications may contribute to the aggravation of severe intra-abdominal infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233010     DOI: 10.3109/00365541003660021

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Rho kinase regulates induction of T-cell immune dysfunction in abdominal sepsis.

Authors:  Z Hasan; K Palani; S Zhang; M Lepsenyi; R Hwaiz; M Rahman; I Syk; B Jeppsson; Henrik Thorlacius
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

2.  A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis.

Authors:  Jonathan S Boomer; Jennifer Shuherk-Shaffer; Richard S Hotchkiss; Jonathan M Green
Journal:  Crit Care       Date:  2012-06-28       Impact factor: 9.097

3.  HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD.

Authors:  Ludvig Linton; Mats Karlsson; Jeanette Grundström; Eric Hjalmarsson; Annelie Lindberg; Emma Lindh; Hans Glise; Ragnar Befrits; Izabella Janczewska; Per Karlén; Ola Winqvist; Michael Eberhardson
Journal:  Clin Transl Gastroenterol       Date:  2012-12-20       Impact factor: 4.488

Review 4.  Statins as modulators of regulatory T-cell biology.

Authors:  David A Forero-Peña; Fredy R S Gutierrez
Journal:  Mediators Inflamm       Date:  2013-10-03       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.